SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

IGF OT IGF Development of an Innovative PSMA Targeted Radionuclide Therapy for Prostate Cancer Period of Performance
Award last edited on: 9/22/2017

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$2,000,000
Award Phase
1
Solicitation Topic Code
NCI
Principal Investigator
Mandie S White

Company Information

Cancer Targeted Technology LLC (AKA: CTT)

14136 NE Woodinville-Duvall Road Suite 143
Woodinville, WA 98072
Location: Single
Congr. District: 01
County: King

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2016
Phase I Amount
$2,000,000
Background Information The Phase II of the contract has four objectives Objective Scale up and analytical characterization of the lead radiotherapeutic agent selected from Phase I Objective Optimization of dose regimen in an animal efficacy model using a PSMA expressing subcutaneous human prostate tumor Objective Maximum Tolerate Dose Study of Lead Lu DOTA PSMA therapeutic agent in normal male rats Objective Assess safety of the radiolabeled lead agent in an IND enabling GLP study in adult male rats Three of these objectives will be pursued by the Subcontractors at University of Pittsburgh

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----